Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Helius Medical Technologies Inc HSDT

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing... see more

Recent & Breaking News (NDAQ:HSDT)

Helius Medical Technologies (TSX:HSM) appoints new VP of Sales & Marketing

Julia Kennedy  June 2, 2021

Helius Medical Technologies, Inc. Appoints Frederick Fantazzia as Vice President of Sales & Marketing, North America

GlobeNewswire June 2, 2021

Helius Medical Technologies, Inc. Reports First Quarter 2021 Financial Results

GlobeNewswire May 17, 2021

Keynotes, Educational Panels and 66 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on April 20-22, 2021

Accesswire April 19, 2021

Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021

GlobeNewswire April 7, 2021

Helius Medical Technologies Inc. (TSX:HSM) receives U.S. marketing authorization for the PoNS(TM) device

John Ballem  March 29, 2021

Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS(TM) Device

GlobeNewswire March 29, 2021

Helius Medical Technologies, Inc. to Present at the Investor Summit Group's Q1 Virtual Summit on March 23rd

GlobeNewswire March 17, 2021

Helius Medical Technologies (TSX:HSM) appoints Sherrie Perkins to its Board of Directors

John Ballem  March 17, 2021

Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of Directors

GlobeNewswire March 17, 2021

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results

GlobeNewswire March 10, 2021

Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021

GlobeNewswire February 2, 2021

Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

GlobeNewswire February 1, 2021

IIROC Trade Resumption - HSM

Canada NewsWire January 28, 2021

Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market

GlobeNewswire January 28, 2021

IIROC Trading Halt - HSM

Canada NewsWire January 28, 2021

Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services' Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices

GlobeNewswire January 20, 2021

Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing Standards

GlobeNewswire January 19, 2021

Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor Conference

GlobeNewswire January 15, 2021

Helius Medical Technologies, Inc. Submits Response to U.S. FDA in Pursuit of De Novo Classification and Clearance of the PoNS(TM) Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis

GlobeNewswire January 11, 2021